CD38 shows especially high and uniform expression on MM cells, in which it plays a relevant role in cancer cell pathology, making it a target of choice for therapeutic antibodies targeting cell surface molecules in MM [42,43,44]. Here, CD38 is linked to Miyoshi myopathy.